0001818382-23-000197.txt : 20231212
0001818382-23-000197.hdr.sgml : 20231212
20231212161032
ACCESSION NUMBER: 0001818382-23-000197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231208
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scheessele William John
CENTRAL INDEX KEY: 0001879378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39532
FILM NUMBER: 231481347
MAIL ADDRESS:
STREET 1: 620 WADE AVENUE
STREET 2: UNIT 501
CITY: RALEIGH
STATE: NC
ZIP: 27605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Humacyte, Inc.
CENTRAL INDEX KEY: 0001818382
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851763759
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-313-9633
MAIL ADDRESS:
STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20200716
4
1
wk-form4_1702415423.xml
FORM 4
X0508
4
2023-12-08
0
0001818382
Humacyte, Inc.
HUMA
0001879378
Scheessele William John
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM
NC
27713
0
1
0
0
Chief Commercial Officer
0
Stock Options (right to buy)
2.80
2023-12-08
4
A
0
276000
0
A
2033-12-08
Common Stock
276000
276000
D
The first 25% of the option becomes exercisable on December 8, 2024, after which 1/48 of the option will become exercisable on the 8th of each month through December 8, 2027.
/s/ William John Scheessele by Dale A. Sander as Attorney-in-Fact
2023-12-12